Timetable
|
PI3-K in the Immune System
Organizers:
Melanie Welham (Bath, UK)
Peter Finan (Novartis, UK)
Sponsors:
The Biochemical Society
|
Biology and Regulation
09:30 - 10:30 Registration
Uncovering the complexity of inositol phospholipid dependent cellular signals
Peter Downes (Dundee, UK)
Impaired B and T cell antigen receptor signalling in p110dPI3-Kinase mutant mice
Bart Vanhaesebroeck (Ludwig Institute for Cancer Research, UK)
PI3-Kinase g - a key modulator in inflammation and allergy
Matthias Wymann (Fribourg, Switzerland)
12:20 - 13:40 Lunch and Poster Session One
Signalling via PI3-Kinases in neutrophils
Phill Hawkins (Babraham Institute, Cambridge, UK)
SHIPs and Doks as regulators of immune cell function
John Cambier (Denver, CO, USA)
The role of SHIP in mast cells and macrophages
Gerry Krystal (Vancouver, Canada)
15:40 - 16:00 Tea/Coffee Break
Role of p110d in neutrophil function
Joel Hayflick (ICOS Corporation, USA)
17:30 - 19:00 Drinks Reception and Poster Session Two
19:30 - 23:00 Meeting Dinner (Ghyll Country Manor Hotel)
|
Oral communications from elevated abstracts
12:20 - 13:40 Lunch and Poster Session One
15:40 - 16:00 Tea/Coffee Break
A role for PI3-K in thymocyte positive selection
Susannah D. Barbee (California Institute of Technology, USA)
The role of PI3-Kinase-gamma in murine neutrophil chemotaxis and function during airway inflammation
Matthew Thomas (Novartis, UK)
Targeting chemokine signaling - An innovative therapeutic strategy
Christian Rommel (Serono Pharmaceutical Research Institute, Switzerland)
17:30 - 19:00 Drinks Reception and Poster Session Two
19:30 - 23:00 Meeting Dinner (Ghyll Country Manor Hotel)
|
Downstream Effectors in Immune Cells
Tuesday 10 September 2002
09:00 - 09:30 Registration
Cytokine-mediated control of proliferation and survival through regulation of Forkhead transcription factors
Paul Coffer (Utrect, The Netherlands)
S6 Kinase signalling and cell growth
George Thomas (Fredrich Miescher Institute, Switzerland)
10:50 - 11:20 Tea/Coffee Break
Signalling and its consequences in T cells
Doreen Cantrell (Cancer Research UK, London, UK)
Regulation of the protein kinase b/akt signalling pathway
Brian Hemmings (Fredrich Miescher Institute, Switzerland)
|